Total Payments
$12,912
2024 Payments
$1,325
Companies
24
Transactions
409
Medicare Patients
502
Medicare Billing
$203,150
Payment Breakdown by Category
Food & Beverage$8,145 (63.1%)
Consulting$3,000 (23.2%)
Other$1,700 (13.2%)
Education$67.60 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,145 | 397 | 63.1% |
| Consulting Fee | $3,000 | 1 | 23.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,700 | 3 | 13.2% |
| Education | $67.60 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $3,097 | 5 | $0 (2023) |
| Allergan, Inc. | $1,685 | 40 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $1,486 | 75 | $0 (2024) |
| ABBVIE INC. | $1,217 | 50 | $0 (2024) |
| Lundbeck LLC | $1,024 | 66 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $630.21 | 33 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $605.19 | 34 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $571.75 | 5 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $564.02 | 22 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $528.30 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,325 | 52 | ABBVIE INC. ($320.15) |
| 2023 | $1,113 | 44 | ABBVIE INC. ($263.80) |
| 2022 | $909.89 | 41 | ABBVIE INC. ($224.61) |
| 2021 | $1,546 | 47 | Supernus Pharmaceuticals, Inc. ($500.00) |
| 2020 | $663.13 | 38 | Otsuka America Pharmaceutical, Inc. ($254.74) |
| 2019 | $1,296 | 73 | Lundbeck LLC ($285.31) |
| 2018 | $1,085 | 64 | Neurocrine Biosciences, Inc. ($264.01) |
| 2017 | $4,974 | 50 | Alkermes, Inc. ($3,000) |
All Payment Transactions
409 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $33.99 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $29.18 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: Neuropsychiatry | ||||||
| 09/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $39.36 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Central Nervous System | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $38.68 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Neuropsychiatry | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Neuropsychiatry | ||||||
| 06/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.28 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 112 | 523 | $79,981 | $46,684 |
| 2022 | 2 | 122 | 563 | $73,154 | $51,587 |
| 2021 | 3 | 160 | 632 | $84,686 | $61,096 |
| 2020 | 2 | 108 | 541 | $64,814 | $43,784 |
Total Patients
502
Total Services
2,259
Medicare Billing
$203,150
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 441 | $70,919 | $41,145 | 58.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 82 | $9,061 | $5,539 | 61.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 464 | $63,500 | $44,890 | 70.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 99 | $9,654 | $6,697 | 69.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 488 | $69,361 | $49,367 | 71.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 133 | $13,013 | $10,145 | 78.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 11 | 11 | $2,311 | $1,584 | 68.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 96 | 529 | $62,808 | $42,564 | 67.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 12 | 12 | $2,006 | $1,220 | 60.8% |
About Dr. Theodore Handrup, MD
Dr. Theodore Handrup, MD is a Psychiatry healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073594974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Theodore Handrup, MD has received a total of $12,912 in payments from pharmaceutical and medical device companies, with $1,325 received in 2024. These payments were reported across 409 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($8,145).
As a Medicare-enrolled provider, Handrup has provided services to 502 Medicare beneficiaries, totaling 2,259 services with total Medicare billing of $203,150. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Chicago, IL
- Active Since 11/08/2005
- Last Updated 11/28/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1073594974
Products in Payments
- Aristada 441 mg (Drug) $3,000
- VRAYLAR (Drug) $2,880
- REXULTI (Drug) $1,922
- LATUDA (Drug) $579.45
- INGREZZA (Drug) $540.42
- TRINTELLIX (Drug) $503.92
- Auvelity (Drug) $381.37
- ABILIFY MAINTENA (Drug) $358.17
- SPRAVATO (Drug) $265.21
- AUSTEDO (Drug) $235.71
- Austedo XR (Drug) $224.00
- Trintellix (Drug) $209.66
- Azstarys (Drug) $158.21
- BRINTELLIX (Drug) $140.43
- INVEGA SUSTENNA (Drug) $112.90
- QUVIVIQ (Drug) $101.28
- VYVANSE (Drug) $98.22
- LYBALVI (Drug) $97.46
- QELBREE (Drug) $71.75
- UZEDY (Drug) $68.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Chicago
Dr. Michelle Dees, Md, MD
Psychiatry — Payments: $523,545
Psychiatry $523,545
Mitchell Glaser, Md, MD
Psychiatry — Payments: $494,195
Psychiatry $494,195
Peter Weiden, Md, MD
Psychiatry — Payments: $202,917
Psychiatry $202,917
Emil Coccaro, M.d, M.D
Psychiatry — Payments: $104,905
Psychiatry $104,905
Jon Grant
Psychiatry — Payments: $86,379
Psychiatry $86,379
Dr. Richard Baer, M.d, M.D
Psychiatry — Payments: $84,125
Psychiatry $84,125